News | July 01, 2022
Jubilant HollisterStier announces CAD 100 mn for Montreal facility
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry
This agreement is in addition to the $92 million filling line expansion announced in November 2021
New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
New product line to address the challenge of restrictions on use of plastic straws
Both companies have been selected for stand-by production by German government
The new unit will be built with INEOS’ latest process technology and aims to substantially improve the sustainability of our supply to our customers and reduce our environmental impact
Subscribe To Our Newsletter & Stay Updated
